BRCA2 and neoplasm: Additionally, some DGC patients tested negative for CDH1/CTNNA1 gene but had pathogenic variants in related tumor susceptibility genes, such as BRCA2, ATM, SDHB, PRSS1, MSR1, STK11, and PALB2 [9].